| NCT02456428 | - | - | Completed | - | Canada, Quebec
... more >> Lady Davis Institute for Medical Research, Jewish General Hospital
Montreal, Quebec, Canada, H3T1E2 Collapse << |
| NCT02476760 | - | - | Completed | - | Canada, Quebec
... more >> Lady Davis Institute for Medical Research, Jewish General Hospital
Montreal, Quebec, Canada, H3T1E2 Collapse << |
| NCT02475499 | - | - | Completed | - | Canada, Quebec
... more >> Lady Davis Institute for Medical Research, Jewish General Hospital
Montreal, Quebec, Canada, H3T1E2 Collapse << |
| NCT02414958 | Diabetes Mellitus, Type 1 | Phase 3 | Completed | - | - |
| NCT02414958 | - | - | Completed | - | - |
| NCT03492580 | - | - | Completed | - | United States, New Jersey
... more >>
Janssen Investigative Site
Titusville, New Jersey, United States, 08560 Collapse << |
| NCT03071692 | Type2 Diabetes
... more >> Dyslipidemia Collapse << | Phase 3 | Recruiting | May 2022 | - |
| NCT01475461 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
| NCT01475461 | - | - | Completed | - | - |
| NCT01068860 | Type 2 Diabetes Mellitus
... more >> Impaired Glucose Tolerance Collapse << | Phase 2 | Completed | - | - |
| NCT00741468 | Drug Interactions | Phase 1 | Completed | - | United States, New Jersey
... more >>
Clinical Research Center Advanced Biomedical Research Inc.
Hackensack, New Jersey, United States, 07601 Collapse << |
| NCT01068860 | - | - | Completed | - | - |
| NCT00741468 | - | - | Completed | - | - |
| NCT01188525 | Healthy Volunteers | Phase 1 | Completed | - | France
... more >> Center of clinical investigation
Paris, France, 75018 Collapse << |
| NCT00082238 | Cystic Fibrosis
... more >> Diabetes Mellitus Collapse << | Not Applicable | Completed | - | United States, Texas
... more >>
University of Texas Southwestern
Dallas, Texas, United States, 75390-9063 Collapse << |
| NCT03723395 | Drug-drug Interaction | Phase 1 | Recruiting | November 2018 | United States, Florida
... more >>
Covance Clinical Research Unit
Recruiting
Daytona Beach, Florida, United States, 32117
Contact: Michelle Saint Pierre 386-366-6428 michelle.saintpierre@covance.com
Principal Investigator: Hugh Coleman
United States, Texas
Covance Clinical Research Unit
Recruiting
Dallas, Texas, United States, 75247
Contact: Iona Tihina 469-513-6716 Ioana.Tihina@covance.com
Principal Investigator: Jennifer Zon Collapse << |
| NCT02819102 | Hereditary Angioedema | Phase 1 | Completed | - | United Kingdom
... more >> Quotient Clinical Ltd
Ruddington, Nottingham, United Kingdom, NG11 6JS Collapse << |
| NCT01218620 | Adult Solid Neoplasm | Phase 1 | Completed | - | United States, Wisconsin
... more >>
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States, 53792 Collapse << |
| NCT02133118 | - | - | Completed | - | Netherlands
... more >> Isala
Zwolle, Overijssel, Netherlands, 8000 AB Collapse << |
| NCT01237522 | Metformin
Org... more >>anic Cation Transporter 2
Polymorphism,Single Nucleotide Collapse << | Phase 4 | Completed | - | Denmark
... more >> Institute of Public Health, Clinical Pharmacology, University of Southern Denmark
Odense, Denmark, 5000 Collapse << |
| NCT01260844 | Moderate to Severe Plaque Psor... more >>iasis Collapse << | Phase 1 | Withdrawn(Study stopped) | - | - |
| NCT00185003 | Endotoxemia | Phase 1 | Completed | - | - |
| NCT00738088 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(Following Regulator... more >> inspection in 2009, study terminated as inadequate approvals were in place) Collapse << | - | United Kingdom
... more >> NHS Tayside
Dundee, United Kingdom, DD1 9SY Collapse << |
| NCT01061112 | - | - | Unknown | June 2014 | United States, Minnesota
... more >>
Clinical and Translational Science Institute
Minneapolis, Minnesota, United States, 55414 Collapse << |
| NCT02473627 | Healthy | Phase 1 | Completed | - | United Kingdom
... more >>
London, United Kingdom, NW10 7EW Collapse << |
| NCT00369304 | Healthy Subjects | Phase 1 | Completed | - | - |
| NCT03457597 | Healthy | Phase 1 | Completed | - | United States, Arizona
... more >>
Celerion
Tempe, Arizona, United States, 85283 Collapse << |
| NCT02291666 | Type 2 Diabetes | Phase 4 | Recruiting | October 2019 | Canada, Quebec
... more >> Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting
Montreal, Quebec, Canada, H2X0A9
Contact: Veronique Michaud, BPharm, PhD 514-8908000 ext 15812 v.michaud@umontreal.ca
Contact: Jacques Turgeon, BPharm,PhD 514-8908045 jacques.turgeon@umontreal.ca
Principal Investigator: Veronique Michaud, BPharm,PhD
Sub-Investigator: Jean-Louis Chiasson, MD
Sub-Investigator: Jacques Turgeon, BPharm,PhD Collapse << |
| NCT02515526 | AOD Effects and Consequences | Not Applicable | Unknown | December 2016 | Germany
... more >> Department of Pharmacology I, University Hospital Cologne
Cologne, NRW, Germany, 50931 Collapse << |
| NCT03103568 | Drug Drug Interaction | Phase 1 | Completed | - | Germany
... more >> PAREXEL EPCU Berlin
Berlin, Germany, 14050 Collapse << |
| NCT01147887 | Healthy | Phase 1 | Completed | - | Belgium
... more >>
Merksem, Belgium Collapse << |
| NCT01525628 | Hepatitis C, Chronic | Phase 1 | Completed | - | United States, California
... more >>
1241.27.0006 Boehringer Ingelheim Investigational Site
La Mesa, California, United States
United States, Maryland
1241.27.0005 Boehringer Ingelheim Investigational Site
Rockville, Maryland, United States
United States, New Jersey
1241.27.0004 Boehringer Ingelheim Investigational Site
Marlton, New Jersey, United States
United States, Pennsylvania
1241.27.0003 Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania, United States
United States, Utah
1241.27.0001 Boehringer Ingelheim Investigational Site
Salt Lake City, Utah, United States
Canada, British Columbia
1241.27.0200 Boehringer Ingelheim Investigational Site
Vancouver, British Columbia, Canada
1241.27.0600 Boehringer Ingelheim Investigational Site
Vancouver, British Columbia, Canada
1241.27.0700 Boehringer Ingelheim Investigational Site
Vancouver, British Columbia, Canada
1241.27.0400 Boehringer Ingelheim Investigational Site
Victoria, British Columbia, Canada
Canada, Ontario
1241.27.0100 Boehringer Ingelheim Investigational Site
London, Ontario, Canada
1241.27.0300 Boehringer Ingelheim Investigational Site
Ottawa, Ontario, Canada
Canada, Quebec
1241.27.0500 Boehringer Ingelheim Investigational Site
Montreal, Quebec, Canada
Germany
1241.27.4901 Boehringer Ingelheim Investigational Site
Frankfurt am Main, Germany
1241.27.4907 Boehringer Ingelheim Investigational Site
Köln, Germany
1241.27.4903 Boehringer Ingelheim Investigational Site
Leipzig, Germany
1241.27.4906 Boehringer Ingelheim Investigational Site
Mainz, Germany Collapse << |
| NCT00930306 | Chronic Pain | Phase 1 | Completed | - | United Kingdom
... more >> Research Site
London, United Kingdom
Research Site
Manchester, United Kingdom Collapse << |
| NCT03716427 | Healthy Volunteers | Phase 1 | Completed | - | United States, Michigan
... more >>
Jasper Clinic
Kalamazoo, Michigan, United States, 49007 Collapse << |
| NCT01525628 | - | - | Completed | - | - |
| NCT02182401 | Healthy | Phase 1 | Terminated | - | - |
| NCT02211079 | Healthy | Phase 1 | Completed | - | Netherlands
... more >>
Groningen, Netherlands Collapse << |
| NCT01185548 | Lymphoma
Adva... more >>nced Cancer Collapse << | Phase 1 | Terminated(Terminated based on... more >> safety results from another trial) Collapse << | - | United Kingdom
... more >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Cardiff, South Glamorgan, United Kingdom, CF14 2TL
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Sheffield, Trent, United Kingdom, S10 2SJ
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Leeds, West Yorkshire, United Kingdom, LS9 7TF
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Leicester, United Kingdom, LE1 5WW
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
London, United Kingdom, WC1E 6BT Collapse << |
| NCT03291288 | Drug Interaction Potential | Phase 1 | Active, not recruiting | March 2019 | United States, Arizona
... more >>
HonorHealth
Scottsdale, Arizona, United States, 85258
University of Arizona
Tucson, Arizona, United States, 85719
United States, California
Stanford University
Palo Alto, California, United States, 94304
United States, Kansas
University of Kansas Cancer Center
Westwood, Kansas, United States, 66205
United States, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
United States, Michigan
Karmanos Cancer Center
Detroit, Michigan, United States, 48201
United States, New York
Northwell Health
Lake Success, New York, United States, 10042
United States, Texas
Mary Crowley Cancer Research
Dallas, Texas, United States, 75230
Netherlands
Leids Universitair Medisch Centrum
Leiden, Netherlands, 2333 ZA
New Zealand
Christchurch Hospital NZ
Christchurch, New Zealand, 8011
Taiwan
National Taiwan University Hospital
Taipei, Taiwan, 10002 Collapse << |
| NCT01185548 | - | - | Terminated(Terminated based on... more >> safety results from another trial) Collapse << | - | - |
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
